对IL-23抑制剂的非标签性皮肤学用途
Justin Porter1, Lacey Zimmerman2, Melissa Nickles2
1University of Illinois College of Medicine, Peoria, IL, USA.
The Journal of dermatological treatment
|December 8, 2024
概括
干白素-23 (IL-23) 抑制剂在治疗除了牛皮之外的各种炎症性皮肤疾病方面表现有前途. 需要进一步的研究来证实它们在这些非标签用途中的有效性和安全性.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 介质素-23 (IL-23) 与各种炎症性皮肤疾病有关.
- 目前FDA批准的IL-23抑制剂 (guselkumab,tildrakizumab,risankizumab) 仅用于牛皮.
- 在几种非牛皮性皮肤病中观察到较高的IL-23水平.
研究的目的:
- 对皮肤病学中IL-23抑制剂的非标签性使用进行审查和解释现有的文献.
- 探索IL-23抑制剂在治疗比牛皮之外的炎症性皮肤疾病方面的潜力.
主要方法:
- 搜索了PubMed和ClinicalTrials.gov的相关研究.
- 包括临床试验,观察性研究,病例系列和病例报告.
- 专注于使用guselkumab,tildrakizumab和risankizumab用于非银病的情况.
主要成果:
- 在hidradenitis suppurativa,平坦,pityriasis rubra pilaris,pyoderma gangrenosum和其他人中观察到有前途的反应.
- 诸如剖析性纤维炎,先天性 Ichthyosiform 红皮病和脱发症等疾病也显示出潜在的益处.
- 红斑性狼和斯图尔特-特雷夫血管肉瘤是报告反应的疾病之一.
结论:
- IL-23抑制剂可能有效治疗各种炎症性皮肤病,因为它们与牛皮有共同的途径.
- 目前的研究结果表明,非标注的适用性有潜在的治疗益处.
- 大规模的随机临床试验对于验证这些疾病的有效性和安全性至关重要.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
01:24T Cell Types and Functions
951
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
951
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476